APGE Institutional Ownership

Apogee Therapeutics, Inc.

Latest close $134.23 as of Aug 5, 2026

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.

Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Jul 8, 2026

Public consensus preview Reduction leaning 30/100 institutional research score

2 tracked institutions Latest filing Jul 8, 2026

1 reducing across 1 comparable institution.

Accumulating0

Unchanged0

Reducing1

Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$34.34 52-week high$133.16

Latest close $134.23 100.0% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Jun 30, 2026

Fidelity / FMR Jul 8, 2026 filed

Wellington Management Group Jul 8, 2026 filed

T. Rowe Price Investment Management Jul 8, 2026 filed

Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 5 parsed filing(s) · 2 older require more history access

Holder	Observed / filed	Reported change	Shares	Ownership	Observation	Filing	Latest
Wellington Management Group CIK0000902219	Jun 30, 2026 observed Jul 8, 2026 filed · 8d Schedule 13G amendment	Earliest Schedule 13G amendment found	564.3K	0.91%	$132.73	$133.25	$134.23
T. Rowe Price Investment Management CIK0001897612	Jun 30, 2026 observed Jul 8, 2026 filed · 8d Schedule 13G amendment	Reported reduction	773.0K -9.5M	12.00% -4.80 pts	$132.73	$133.25	$134.23
Fidelity / FMR CIK0000315066	Jun 30, 2026 observed Jul 8, 2026 filed · 8d Schedule 13G amendment	Earliest Schedule 13G amendment found	2.5K	12.00%	$132.73	$133.25	$134.23

Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

SBET SHARPLINK INC 30/100 Reduction leaning USFD US FOODS HOLDING CORP 30/100 Reduction leaning YETI YETI HOLDINGS INC 30/100 Reduction leaning HAIN HAIN CELESTIAL GROUP INC 30/100 Reduction leaning

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026